TEANECK, N.J. — Phibro Animal Health Corp. has announced its financial results for its second quarter ended Dec. 31, 2017.
Highlights include: net sales of $206 million, an increase of $14 million, or 7 percent; net income of $7 million, a decrease of $6 million, or 48 percent; diluted EPS (earnings per share) of 17 cents, a decrease of 17 cents, or 50 percent; adjusted diluted EPS of 44 cents, an increase of 5 cents, or 13 percent.
"We are encouraged by the development of our business, and as a result are increasing our financial guidance as compared with the. . .
Register or Login to keep reading
Thank you for your interest in accessing the complete content. To continue reading, please register for free. By registering, you'll gain full access to our valuable resources, updates, and insights.
If you already have an account please Log In.
